All News
Filter News
Found 808,690 articles
-
Adial Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
11/14/2022
Adial Pharmaceuticals, Inc today provided a business update and reported its financial results for the third quarter of 2022.
-
Oxford Biomedica to complete sale and leaseback of Windrush Court facility for £60 million
11/14/2022
Oxford, UK – 14November 2022: Oxford Biomedica plc, a leading gene and cell therapy group, announces exchange of contracts for the sale of its Windrush Court facility to Kadans Science Partner for £60 million.
-
Volition Announces Clinical Research Study with Oncovet
11/14/2022
VolitionRx Limited has announced a clinical research study with Oncovet, a renowned veterinary referral clinic, specializing in medical and radiation oncology.
-
Ascendis Pharma Submits Marketing Authorisation Application to the European Medicines Agency for TransCon™ PTH in Adult Patients with Hypoparathyroidism
11/14/2022
Ascendis Pharma A/S announced it has submitted a Marketing Authorisation Application to the European Medicines Agency for TransCon PTH in adult patients with hypoparathyroidism.
-
Code Biotherapeutics Names Alex S. Tracy, PhD, as Chief Technical Officer
11/14/2022
Code Biotherapeutics, Inc. today announces the appointment of Alex Tracy, PhD, as Chief Technical Officer.
-
BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York
11/14/2022
BIOLASE, Inc., the global leader in dental lasers, announced it has been invited to participate in the 11th Annual Benchmark Discovery One-on-One Investor Conference taking place December 1, 2022 in New York City.
-
Mast Cell Levels May Explain Sex Differences in Osteoarthritis Pain
11/14/2022
Investigators at Hospital for Special Surgery have discovered that at the time of total knee replacement, women have significantly increased levels of immune cells called mast cells in synovial tissue surrounding the knee joint than men.
-
AIM ImmunoTech Announces Presentation of New Data from Roswell Park Comprehensive Cancer Center Evaluating Ampligen® as a Component of a CKM Regimen, with Paclitaxel, for the Treatment of Early-Stage Triple Negative Breast Cancer
11/14/2022
AIM ImmunoTech Inc. announced the presentation of positive data from research led by Roswell Park Comprehensive Cancer Center medical oncologist Shipra Gandhi, MD, evaluating Ampligen® as a component of a CKM regimen for the treatment of early-stage triple negative breast cancer.
-
Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany
11/14/2022
Co-Diagnostics, Inc. announced that it will be hosting a booth this week at the MEDICA 2022 trade fair in Düsseldorf, Germany from 15-17 November.
-
ViewRay® to Participate in the 34th Annual Piper Sandler Healthcare Conference
11/14/2022
ViewRay, Inc. announced that the Company will present at the 34th Annual Piper Sandler Healthcare Conference.
-
Tivic Health Reports Third Quarter 2022 Financial Results
11/14/2022
Tivic Health ® Systems, Inc. today announced its financial results for the quarter ended September 30, 2022.
-
RenovoRx Reports Third Quarter 2022 Financial Results
11/14/2022
RenovoRx, Inc today reported its financial results for the quarter ended September 30, 2022.
-
Renibus Therapeutics Raises $33 Million Bridge Financing to Advance its Portfolio of Cardiorenal Product Candidates
11/14/2022
Renibus Therapeutics, Inc. announced a $33 million bridge financing consisting of a $23 million SAFE offering and $10 million pursuant to the first tranche of a $30 million term loan with Oxford Finance LLC.
-
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
11/14/2022
Diffusion Pharmaceuticals Inc. provided an update on the Company’s previously announced review and evaluation of strategic opportunities and its 2022 annual meeting of stockholders to be held on December 30, 2022.
-
Rhinostics and LVL technologies Partner to Provide Decapping Solutions for Automated Collection Device Workflows
11/14/2022
Rhinostics Inc. is excited to announce an expanded partnership with LVL technologies GmbH, which includes Rhinostics’ reselling of LVL’s decapper instrument and LVL’s distribution of Rhinostics’ automated collection devices in Germany and Austria.
-
Immunome Reports Third Quarter 2022 Financial Results
11/14/2022
Immunome, Inc. today reported financial results for the third quarter ended September 30, 2022 and provided a corporate update.
-
Ionis partners with Metagenomi to add gene editing to its broad technology platform
11/14/2022
Ionis Pharmaceuticals, Inc. and Metagenomi announced that the companies have entered a collaboration that will leverage Ionis' extensive expertise in RNA-targeted therapeutics and Metagenomi's versatile next-generation gene editing systems to pursue a mix of validated and novel genetic targets that have potential to expand therapeutic options for patients.
-
Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0
11/14/2022
Agilent Technologies Inc. (NYSE: A) today announced the release of the AssayMAP Bravo Protein Sample Prep Workbench 4.0 software.
-
Gaumard Scientific Announces First Installation of Robotic Patient Simulator with Conversational Speech, HAL® S5301, at Emory Nursing Learning Center
11/14/2022
Gaumard Scientific Co. announced that HAL® S5301, the world's most advanced interdisciplinary patient simulator, has been installed at the Emory University Nell Hodgson Woodruff School of Nursing's new state-of-the-art simulation and learning center.
-
PharmaTher Announces Poster Presentation of Positive Efficacy and Safety Data from Phase 1/2 Clinical Study of Ketamine in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease at Neuroscience 2022 by the Society for Neuroscience
11/14/2022
PharmaTher Holdings Ltd. announced that a poster presentation of the Phase 1/2 clinical study of ketamine in the treatment of levodopa-induced dyskinesia in Parkinson’s disease was presented at Neuroscience 2022 by the Society for Neuroscience being held November 12-16, 2022, at the San Diego Convention Center in San Diego, California.